Requirements for membrane attack complex formation and anaphylatoxins binding to collagen-activated platelets

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Martel, Catherine ^a   Cointe, Sylvie ^a   Maurice, Pascal ^a   Matar, Saïd ^a   Ghitescu, Marta ^a   Théroux, Pierre ^a   Bonnefoy, Arnaud ^a,b  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ANAPHYLATOXIN; CALCIMYCIN; CITRATE SODIUM; COLLAGEN; COLLAGEN FIBER; COMPLEMENT COMPONENT C3 RECEPTOR; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C4A; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT MEMBRANE ATTACK COMPLEX; CONVULXIN; EGTAZIC ACID; HIRUDIN; MAGNESIUM ION; N ACETYLGALACTOSAMINE 4 SULFATASE; PADGEM PROTEIN; PHOSPHATIDYLSERINE; RECEPTOR BLOCKING AGENT; COMPLEMENT C3A RECEPTOR; COMPLEMENT RECEPTOR; HIRUDIN DERIVATIVE; LECTIN; SNAKE VENOM; THROMBIN RECEPTOR;

ARTICLE; BLOOD CLOTTING; CELL SUBPOPULATION; CELL SURFACE; COMPLEMENT ACTIVATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; WESTERN BLOTTING; CYTOLOGY; DRUG EFFECT; KINETICS; METABOLISM; PROTEIN BINDING; SOLUBILITY; THROMBOCYTE; THROMBOCYTE RICH PLASMA;

ADENOSINE DIPHOSPHATE; ANAPHYLATOXINS; BLOOD PLATELETS; CALCIMYCIN; COLLAGEN; COMPLEMENT MEMBRANE ATTACK COMPLEX; CROTALID VENOMS; HIRUDINS; HUMANS; KINETICS; LECTINS, C-TYPE; P-SELECTIN; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET-RICH PLASMA; PROTEIN BINDING; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, COMPLEMENT; RECEPTORS, THROMBIN; SIGNAL TRANSDUCTION; SOLUBILITY;

EID: 79954469179     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018812     Document Type: Article

References (30)

1. Polley MJ, Nachman RL, (1979) Human complement in thrombin-mediated platelet function: uptake of the C5b-9 complex. J Exp Med 150: 633-645.
2. Tedesco F, Densen P, Villa MA, Presani G, Roncelli L, et al. (1986) Functional C8 associated with human platelets. Clin Exp Immunol 66: 472-480.
3. Houle JJ, Leddy JP, Rosenfeld SI, (1989) Secretion of the terminal complement proteins, C5-C9, by human platelets. Clin Immunol Immunopathol 50: 385-393.
4. Wiedmer T, Sims PJ, (1985) Effect of complement proteins C5b-9 on blood platelets. Evidence for reversible depolarization of membrane potential. J Biol Chem 260: 8014-8019.
5. Chang CP, Zhao J, Wiedmer T, Sims PJ, (1993) Contribution of platelet microparticle formation and granule secretion to the transmembrane migration of phosphatidylserine. J Biol Chem 268: 7171-7178.
6. Wiedmer T, Esmon CT, Sims PJ, (1986) Complement proteins C5b-9 stimulate procoagulant activity through platelet prothrombinase. Blood 68: 875-880.
7. Wiedmer T, Ando B, Sims PJ, (1987) Complement C5b-9-stimulated platelet secretion is associated with a Ca2+-initiated activation of cellular protein kinases. J Biol Chem 262: 13674-13681.
8. Peerschke EI, Yin W, Ghebrehiwet B, (2010) Complement activation on platelets: implications for vascular inflammation and thrombosis. Mol Immunol 47: 2170-2175.
9. Del Conde I, Cruz MA, Zhang H, Lopez JA, Afshar-Kharghan V, (2005) Platelet activation leads to activation and propagation of the complement system. J Exp Med 201: 871-879.
10. Peerschke EI, Yin W, Grigg SE, Ghebrehiwet B, (2006) Blood platelets activate the classical pathway of human complement. J Thromb Haemost 4: 2035-2042.
11. Hamad OA, Ekdahl KN, Nilsson PH, Andersson J, Magotti P, et al. (2008) Complement activation triggered by chondroitin sulfate released by thrombin receptor-activated platelets. J Thromb Haemost 6: 1413-1421.
12. Seelen MA, Roos A, Wieslander J, Mollnes TE, Sjöholm AG, et al. (2005) Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J Immunol Methods 296: 187-198.
13. Frojmovic MM, Wong T, (1990) The platelet extinction coefficient measured by aggregometry is dependent on platelet composition rather than size: implications for studies of platelet heterogeneity and abnormalities. Thromb Haemost 64: 582-588.
14. Caughman GB, Boackle RJ, Vesely J, (1982) A postulated mechanism for heparin's potentiation of C1 inhibitor function. Mol Immunol 19: 287-295.
15. Kazatchkine MD, Fearon DT, Metcalfe DD, Rosenberg RD, Austen KF, (1981) Structural determinants of the capacity of heparin to inhibit the formation of the human amplification C3 convertase. J Clin Invest 67: 223-228.
16. Bexborn F, Engberg AE, Sandholm K, Mollnes TE, Hong J, et al. (2009) Hirudin versus heparin for use in whole blood in vitro biocompatibility models. J Biomed Mater Res A; 89: 951-959.
17. Huber-Lang M, Sarma JV, Zetoune FS, Rittirsch D, Neff TA, et al. (2006) Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med 12: 682-687.
18. Hugo F, Krämer S, Bhakdi S, (1987) Sensitive ELISA for quantitating the terminal membrane C5b-9 and fluid-phase SC5b-9 complex of human complement. J Immunol Methods 99: 243-251.
19. Peerschke EI, Reid KB, Ghebrehiwet B, (1993) Platelet activation by C1q results in the induction of alpha IIb/beta 3 integrins (GPIIb-IIIa) and the expression of P-selectin and procoagulant activity. J Exp Med 178: 579-587.
20. Hamad OA, Nilsson PH, Wouters D, Lambris JD, Ekdahl KN, et al. (2010) Complement component C3 binds to activated normal platelets without preceding proteolytic activation and promotes binding to complement receptor 1. J Immunol 184: 2686-2692.
21. Sims PJ, Faioni EM, Wiedmer T, Shattil SJ, (1988) Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 263: 18205-18212.
22. Yin W, Ghebrehiwet B, Peerschke EI, (2008) Expression of complement components and inhibitors on platelet microparticles. Platelets 19: 225-233.
23. Siljander P, Carpen O, Lassila R, (1996) Platelet-derived microparticles associate with fibrin during thrombosis. Blood 87: 4651-4663.
24. Dale GL, (2005) Coated-platelets: an emerging component of the procoagulant response. J Thromb Haemost 3: 2185-2192.
25. Kulkarni S, Jackson SP, (2004) Platelet factor XIII and calpain negatively regulate integrin αIIbβ3 adhesive function and thrombus growth. J Biol Chem 279: 30697-30706.
26. Fukuoka Y, Hugli TE, (1988) Demonstration of specific C3a receptor on guinea pig platelets. J Immunol 140: 3496-3501.
27. Yancey KB, Lawley TJ, Dersookian M, Harvath L, (1989) Analysis of the interaction of human C5a and C5a des Arg with human monocytes and neutrophils: flow cytometric and chemotaxis studies. J Invest Dermatol 92: 184-189.
28. Legler DF, Loetscher M, Jones SA, Dahinden CA, Arock M, et al. (1996) Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1. Eur J Immunol 26: 753-758.
29. Bamberg CE, Mackay CR, Lee H, Zahra D, Jackson J, et al. (2010) The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction. J Biol Chem 285: 7633-7644.
30. Watanabe H, Kuraya M, Kasukawa R, Yanagisawa H, Yanagisawa M, et al. (1995) Analysis of C5a receptor by monoclonal antibody. J Immunol Methods 185: 19-29.